Nottingham, UK – 17 June 2013 – Source BioScience plc (“Source BioScience”) has extended the reach of its rapid, market leading DNA sequencing and data analysis service in the UK with today’s launch of its Overnight Service in Scotland.
The Overnight Service will now be available to research groups in and around Edinburgh and Glasgow, with customers receiving their sequencing results by 09.00 the following day, including Saturdays, at no extra cost.
This sequencing and data analysis service has been operational since 2011, when it was launched in London, Cambridge and the Midlands and more recently has been extended across Europe in Berlin and Dublin. The service offers free sample collection and rapid delivery of results, combining Source BioScience’s world class sequencing capabilities with its unique SpeedREAD™ automated data delivery system.
Dr Nick Ash, CEO at Source BioScience, commented: “Our Overnight Service continues to set new standards in sequencing services and can play a major part in reducing downtime in research projects by delivering results in a timely fashion.”
He added, “The Overnight Service is already having a very positive impact on our business, with a significant increase in sequencing volumes since its launch in 2011. We are delighted to extend the service to our Scottish customers, following the acquisition in April of Inverclyde Biologicals, based in Motherwell, and look forward to broadening the reach of this service even further, enabling more customers to access the benefits of overnight sequencing.”
Notes to Editors
About Source BioScience
Source BioScience plc (LSE: SBS) is an international diagnostics and genetic analysis business serving the healthcare and research markets. The LifeSciences division provides core laboratory research support from conceptualisation to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. The Group is a trusted provider of a complete range of sophisticated microarray, next generation and conventional sequencing services. GLP, GCP and CPA accreditations make the sequencing offerings also very attractive for applications in regulatory studies or clinical settings. Its Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases in addition to complementary products for serology and diagnostic applications. The Group has its headquarters in Nottingham, UK. Further information about Source BioScience can be found at www.sourcebioscience.com.
Issued for and on behalf of Source BioScience.
To contact the Source BioScience team at College Hill, email SourceBioScience@collegehill.com
Melanie Toyne-SewellManaging Partner